MS in the Media - 29 November 2019
23 - 29 November 2019
These are links to news stories about multiple sclerosis from the last week that may be of interest to people affected by MS in the UK. The link beneath each item will take you to the original story.
Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.
To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter, or regular email alerts.
Mavenclad eligibility changed
People in England taking Mavenclad no longer need a gadolinium enhanced MRI scan prior to treatment following a change in NICE's guidance.
Source: Pharma Times
MS Trust link: Mavenclad (cladribine)
MS in the Media
20 Nov 2020 - 00:00
- New study for advanced MS
- Campaign for fair benefits during the pandemic
- Stem cells compared to Lemtrada
- DMD use and finances
David Martin appointed Chair of the Neurological Alliance
18 Nov 2020 - 00:00
The MS Trust is delighted to announce that CEO David Martin, has been voted in as Chair of the Neurological Alliance.
My MS and my mental health
16 Nov 2020 - 00:00
In his latest blog, Ian Daly speaks candidly about his own experience with depression and urges others to seek help if needed.
Sign up to our emails
Get the latest news and research sent straight to your inbox. Find out first about the latest developments in MS treatments, plus updates on the work of the MS Trust.
Share
Social care problems highlighted
A BBC report included a woman with MS who spent nearly a year in a care home for older people as services weren't available to help her stay at home. She is currently paying for her own care following the sale of her home, but expects that money to run out by Christmas when she will again be reliant on social services.
Source: BBC
MS Trust link: Social care